Markets:

Overview

News

Currencies

International

Treasuries

Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

15.79 -0.15 (-0.97%)

Delayed Quote Updated: 3:26 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aurinia Pharmaceuticals Inc - Common Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Unusual Options Activity Insight: Aurinia Pharmaceuticals ↗

June 03, 2021

Aurinia Pharmaceuticals (NASDAQ:AUPH) shares experienced unusual options activity on Thursday. The stock price moved down to $13.6 following the option alert. Sentiment: BEARISH...

Via Benzinga

The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements ↗

June 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (...

Via Benzinga

Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

May 27, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Aurinia Pharma Stock Showing A Potential Reversal Pattern: 4 Key Levels To Watch ↗

April 20, 2021

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) was trending Tuesday afternoon poss...

Via Benzinga

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗

May 31, 2021

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...

Via Benzinga

Aurinia's Lupkynis Shows Sustained Renal Response Rates In Lupus Nephritis Patients ↗

May 21, 2021

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has announced a supportive interim analysis of its AURORA 2 continuation study evaluating Lupkynis (voclosporin) in...

Via Benzinga

Aurinia To Present Supportive AURORA 2 Continuation Study Interim Analysis Demonstrating Long-Term Safety & Efficacy of LUPKYNIS™ (voclosporin) in Subjects with Lupus Nephritis

May 20, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

2 Grossly Undervalued Biotech Stocks That Could Double Your Money ↗

May 19, 2021

Aurinia Pharmaceuticals and Agenus might be poised for a healthy growth spurt.

Via The Motley Fool

Another Tough Day For Markets ↗

May 17, 2021

The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.”

Via Talk Markets

Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences

May 14, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Heavy Global Erosion ↗

May 11, 2021

It is an everything-down day. Even the news is down because commenters are being careful.

Via Talk Markets

Aurinia Unveils Patient Navigation Grant Program to Address Access Barriers for Individuals Living with Lupus and Lupus Nephritis

May 10, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗

May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

May 10, 2021

Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT)....

Via Benzinga

Aurinia Pharma's Stock Gains After Lupkynis Data From Late-Stage Lupus Nephritis Study Published In Lancet ↗

May 10, 2021

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has announced that The Lancet published its Phase 3 AURORA 1 study evaluating Lupkynis (voclosporin) in adults with...

Via Benzinga

Aurinia Announces Publication of AURORA 1 Phase 3 Study Results with LUPKYNIS™ (voclosporin) in The Lancet

May 10, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Calm Markets Day ↗

May 07, 2021

Despite seriously disappointing April jobless numbers, markets are gaining all the same.

Via Talk Markets

70 Biggest Movers From Friday ↗

May 10, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday. Velocity Financial, Inc. (NYSE: VEL) rose 36.6% to close at $12.50 following Q1...

Via Benzinga

Cramer Shares His Thoughts On Atkore, Petco And More ↗

May 07, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he prefers American Electric Power Company Inc (NASDAQ: AEP) over Consolidated Edison, Inc. (NYSE: ED). If...

Via Benzinga

56 Stocks Moving In Friday's Mid-Day Session ↗

May 07, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321. Regional Health Properties, Inc. (NYSE: RHE) gained 43% to $21.40 after dropping 23% on Thursday....

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 07, 2021

Friday's morning session saw 17 companies set new 52-week lows. Key Facts: Beyond Meat (NASDAQ:BYND) was the largest firm on a market cap basis to set a new 52-...

Via Benzinga

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗

May 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...

Via Benzinga

32 Stocks Moving in Friday's Pre-Market Session ↗

May 07, 2021

Gainers Assertio Holdings, Inc. (NASDAQ: ASRT) shares rose 44.2% to $0.7190 in pre-market trading after the company reported better-than-expected Q1 results. iBio, Inc. (NYSE:...

Via Benzinga

Why Aurinia Pharmaceuticals Stock Is Crashing Today ↗

May 06, 2021

Expectations for the biotech's first-quarter sales may have been too high.

Via The Motley Fool

Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights

May 06, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Aurinia Pharmaceuticals to Release First Quarter 2021 Financial Results on May 6, 2021

April 28, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue ↗

April 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.